Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 240-462-2 | CAS number: 16411-33-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Based on the available information from the key acute oral toxicity study, the LD50 for N,N',N''-tributyl-1-methyl-silanetriamine was concluded to be between 300 and 2000 mg/kg bw. The study was conducted according to OECD test guideline 423 and to GLP (BSL Bioservice, 2004).
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 10/05/2004 - 27/05/2004
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- other: HsdBrlHan: WIST
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Winkelmann GmbH
- Age at study initiation: not included
- Weight at study initiation: 152-172 g
- Fasting period before study: overnight
- Housing: Macrolon cages on Altromin saw fibre bedding
- Diet (e.g. ad libitum): Altromin 1324 maintenance diet for rats and mice ad libitum
- Water (e.g. ad libitum): tap water
- Acclimation period: adequate acclimation period
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3
- Humidity (%): 55 +/- 10 %
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw
- Doses:
- starting dose of 2000 mg/kg bw
second and third doses of 300 mg/kg bw - No. of animals per sex per dose:
- 3 females - 2000 mg/kg bw
step 1: 3 females - 300 mg/kg bw
step 2: 3 females - 300 mg/kg bw - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: The animals were weighed prior to the treatment and once a week thereafter. Three observations were made within the first four hours after the administration of the article, then daily for the 14-day study period.
- Necropsy of survivors performed: yes
- Other examinations performed: Particular attention was paid to changes in the skin and fur, eyes and mucous membranes, respiratory, circulatory, autonomic and central nervous systems and somatomotor activity and behaviour pattern were examined. Also, attention was directed to observations of tremor, convulsions, salivation, diarrhoea, lethargy, sleep and coma. - Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 300 - < 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: The criteria for determining exact LD50, in accordance with OECD TG 423 were not met; however, based on the 100% mortality at the 2000 mg/kg dose (high dose), it is concluded that the result falls into CLP criteria IV (<2000 mg/kg bw)
- Mortality:
- The dosage of 2000 mg/kg bw caused 100 % mortality within 100 minutes post-dose.
The dosage of 300 mg/kg bw did not cause any mortality in the 2 groups of females tested within 14 days post-dose. - Clinical signs:
- The rats treated with 2000 mg/kg bw experienced reduced spontaneous activity, apathy, prone position, convulsions, incoordination, disturbed locomotor system, laboured respiration, cyanotic head, extremities and tails within 100 minutes after the treatment. No clinical signs of toxicity were observed in the first group of animals treated with 300 mg/kg bw. The second group of animals treated with 300 mg/kg showed signs of apathy and rough coat for the first 30 minutes post-dosage. 60 minutes after the treatment no clinical changes were observed.
- Body weight:
- Throughout the 14-day study observation no weight loss was recorded in the two groups of rats treated with 300 mg/kg bw. The weight gain that was experienced by them was within the expected range.
- Gross pathology:
- The animals treated with 2000 mg/kg bw had cyanotic cutaneous mucosa, bloody gastric and small intestine mucosa, and bloody contents were found at necropsy. No gross pathological changes were found in the two groups of animals treated with 300 mg/kg bw.
- Other findings:
- Acute injection of blood vessels in the abdominal region was observed, which was due to the euthanasia injection.
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- An LD50 for N,N',N''-tributyl-1-methyl-silanetriamine was concluded to be between 300 and 2000 mg/kg bw. The study was conducted according to OECD test guideline 423 and to GLP.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
The key study for acute oral toxicity, conducted according to OECD TG 423 and in compliance with GLP, reports an LD50 of >300 to < 2000 mg/kg bw in female rats for N,N',N''-tributyl-1-methylsilanetriamine (BSL Bioservice, 2004).
At 2000 mg/kg bw, the clinical signs observed included reduced spontaneous activity, apathy, prostration, convulsions, incoordination, disturbed locomotor system activity, laboured respiration, cyanotic head, extremities and tails. All 3 animals in the 2000 mg/kg bw group were deceased by 100 minutes post-treatment. At necropsy, cyanotic cutaneous mucosa, bloody gastric and small intestine mucosa, and bloody contents were observed.
At 300 mg/kg bw, the 6 female rats tested, showed no evident body weight
or pathological changes within the 14-day observation period. There were
no mortalities. Rough coat and signs of apathy were observed from 30
minutes until 60 minutes post-treatment. No gross pathological changes
were found in the animals treated with 300 mg/kg bw.
Justification for classification or non-classification
Based on the available data, N,N',N''-tributyl-1-methylsilanetriamine is classified for Acute Oral Toxicity, Category 4, 'H302: Harmful if swallowed' according to Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.